CD4+ T cell–mediated HLA class II cross-restriction in HIV controllers
暂无分享,去创建一个
Jamie Rossjohn | J. Rossjohn | S. Gras | D. Benati | L. Chakrabarti | H. Reid | Stephanie Gras | Daniela Benati | Carine Farenc | Moran Galperin | Madhura Mukhopadhyay | Dhilshan Jayasinghe | Amandine Decroos | Li Lynn Tan | Lisa Ciacchi | Hugh H. Reid | Lisa A. Chakrabarti | L. L. Tan | D. Jayasinghe | M. Galperin | C. Farenc | M. Mukhopadhyay | A. Decroos | Lisa Ciacchi | Dhilshan Jayasinghe
[1] M. A. van der Hoorn,et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. , 2003, Blood.
[2] Victor Appay,et al. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. , 2013, Immunity.
[3] O. Lambotte,et al. HIV Controller CD4+ T Cells Respond to Minimal Amounts of Gag Antigen Due to High TCR Avidity , 2010, PLoS pathogens.
[4] E. Rosenberg,et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction , 2007, Nature Immunology.
[5] Mark M. Davis,et al. T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone , 2017, Journal of Virology.
[6] P. Gregersen,et al. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. , 1988, Journal of immunology.
[7] James McCluskey,et al. T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.
[8] A. Sette,et al. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. , 2001, The Journal of clinical investigation.
[9] David A. Price,et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.
[10] Pierre Lechat,et al. Public T cell receptors confer high-avidity CD4 responses to HIV controllers. , 2016, The Journal of clinical investigation.
[11] J. Goedert,et al. Killer cell immunoglobulin – like receptor 3 DL 1 variation modifies HLA-B * 57 protection against HIV-1 , 2018 .
[12] Jeffrey N. Martin,et al. HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses , 2010, Journal of Virology.
[13] J. Goedert,et al. Killer cell immunoglobulin–like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1 , 2018, The Journal of clinical investigation.
[14] P. Vidalain,et al. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells , 2000, Gene Therapy.
[15] Todd M. Allen,et al. Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion , 2016, Immunity.
[16] M. Carrington,et al. Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control , 2013, Nature Medicine.
[17] Asier Sáez-Cirión,et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.
[18] O. Lambotte,et al. HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term , 2012, Journal of Virology.
[19] Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. , 2009, Blood.
[20] Colin R. F. Monks,et al. Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.
[21] Michael Loran Dustin,et al. Signaling and Polarized Communication Across the T Cell Immunological Synapse. , 2016, Annual review of cell and developmental biology.
[22] D. Costagliola,et al. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV , 2009, AIDS.
[23] S. Lewin,et al. HIV cure and eradication: how will we get from the laboratory to effective clinical trials? , 2011, AIDS.
[24] E. Rosenberg,et al. HIV-Specific Cytolytic CD4 T Cell Responses During Acute HIV Infection Predict Disease Outcome , 2012, Science Translational Medicine.
[25] D. Watkins,et al. Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection , 2009, Proceedings of the National Academy of Sciences.
[26] M. Lederman,et al. Towards an HIV cure: a global scientific strategy , 2012, Nature Reviews Immunology.
[27] Todd M. Allen,et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection , 2012, Nature Immunology.
[28] Todd M. Allen,et al. Effects of thymic selection of the T cell repertoire on HLA-class I associated control of HIV infection , 2010, Nature.
[29] Z. Grossman,et al. HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity , 2003, The Journal of experimental medicine.
[30] Brigitte Autran,et al. Escape from highly effective public CD8+ T-cell clonotypes by HIV. , 2011, Blood.
[31] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[32] M. Robb,et al. Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia , 2015, Journal of Virology.
[33] J. Goedert,et al. Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells , 2018, Science.